Update on Mpox: What the Primary Care Clinician Should Know.
Level V
Where this comes from
- Record sourced from PubMed, PMID 38331485.
- Also identified by DOI 10.1016/j.mcna.2023.09.005 and PMC identifier 10853636.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Mpox is a viral infection, which primarily caused sporadic outbreaks in West and Central Africa until causing a global epidemic in 2022. The disease has disproportionately affected people with human immunodeficiency virus and men who have sex with men. Transmission is through close physical contact, including sexual contact. Infection presents with a characteristic rash, with frequent anogenital involvement-polymerase chain reaction of skin lesions is diagnostic. Vaccination is available for primary prevention and postexposure prophylaxis. Treatment consists of supportive care, with antiviral medications available via clinical trials and/or for patients with severe disease.
Medical subject headings
- Mpox, Monkeypox
- Sexual and Gender Minorities